You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 29, 2023

Scherer Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SCHERER LABS, and what generic and branded alternatives to SCHERER LABS drugs are available?

SCHERER LABS has six approved drugs.

Summary for Scherer Labs

US Patents:	0
Tradenames:	6
Ingredients:	4
NDAs:	6

Drugs and US Patents for Scherer Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Scherer Labs	CODEINE, ASPIRIN, APAP FORMULA NO. 2	acetaminophen; aspirin; codeine phosphate	CAPSULE;ORAL	085640-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Scherer Labs	CODEINE, ASPIRIN, APAP FORMULA NO. 4	acetaminophen; aspirin; codeine phosphate	CAPSULE;ORAL	085638-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Scherer Labs	MEPROBAMATE	meprobamate	TABLET;ORAL	083343-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Scherer Labs	PREDNISONE	prednisone	TABLET;ORAL	080371-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Scherer Labs	QUINIDINE SULFATE	quinidine sulfate	TABLET;ORAL	085068-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys

Johnson and Johnson

Express Scripts

Colorcon

McKesson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.